BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35917943)

  • 61. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
    Huang S; Jin A
    J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
    Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
    J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LY404039 Inhibits Proliferation and Metastasis of Osteosarcoma Cells via PI3K Signaling Pathway.
    Wu S; Feng Z; Wei B; Jiang L
    Ann Clin Lab Sci; 2019 May; 49(3):291-296. PubMed ID: 31308026
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin.
    Wu J; Liao Q; He H; Zhong D; Yin K
    Mol Carcinog; 2014 Jun; 53(6):440-6. PubMed ID: 23280703
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
    Liu B; Xu L; Dai EN; Tian JX; Li JM
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-κB/cyclinD1 signaling pathway.
    He S; Chen M; Lin X; Lv Z; Liang R; Huang L
    Eur J Pharmacol; 2020 Jan; 867():172811. PubMed ID: 31756335
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
    Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC
    Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
    Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
    Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
    Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
    Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
    Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NPR3, transcriptionally regulated by POU2F1, inhibits osteosarcoma cell growth through blocking the PI3K/AKT pathway.
    Li S; Guo R; Peng Z; Quan B; Hu Y; Wang Y; Wang Y
    Cell Signal; 2021 Oct; 86():110074. PubMed ID: 34229087
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
    Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
    Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
    Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR/PI3K/Akt signaling and NF-κB activation.
    Xu HB; Chen XZ; Yu ZL; Xue F
    J Ethnopharmacol; 2023 Jan; 301():115855. PubMed ID: 36280019
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The expression and function of miRNA-106 in pediatric osteosarcoma.
    Xu M; Zhang YY; Wang HF; Yang GS
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):715-722. PubMed ID: 28272712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway.
    Liang K; Liao L; Liu Q; Ouyang Q; Jia L; Wu G
    Clin Transl Oncol; 2021 Nov; 23(11):2350-2357. PubMed ID: 34133001
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
    Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
    J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.